Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesolipo® Protocol for Localized Adiposity
NCT07743788Completed
- Sponsor
- Antony Barbosa Institute
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Randomised trial of Mesolipo in localized adiposity (AL) (2 arms), sponsored by Antony Barbosa Institute. Primary endpoints: Treatment efficacy at 90 days and Treatment Safety at 90 days. Started Jan 2025; status: completed.
02
Drugs
Mesolipo
03
Conditions
localized adiposity (AL)
Beyond the preview
Go deeper on NCT07743788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07743788.